Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features
about
Thrombophilia and pregnancyEffects of thrombin, PAR-1 activating peptide and a PAR-1 antagonist on umbilical artery resistance in vitroFetal growth: a review of terms, concepts and issues relevant to obstetricsExercise as an intervention to improve metabolic outcomes after intrauterine growth restrictionThe transplacental transfer of IgG subclasses: influence of prematurity and low birthweight in the Gambian population.The placental syncytium and the pathophysiology of preeclampsia and intrauterine growth restriction: a novel assay to assess syncytial protein expressionDiagnosis of placental abruption: relationship between clinical and histopathological findings.Defining normal and abnormal fetal growth: promises and challenges.Prenatal diagnosis of a placental infarction hematoma associated with fetal growth restriction, preeclampsia and fetal death: clinicopathological correlation.Placental vascular pathology and increased thrombin generation as mechanisms of disease in obstetrical syndromes.Endothelin and platelet-activating factor: significance in the pathophysiology of ischemia/reperfusion-induced fetal growth restriction in the ratThe role of proteoglycans in contributing to placental thrombosis and fetal growth restrictionPlacental genome and maternal-placental genetic interactions: a genome-wide and candidate gene association study of placental abruptionAdeno-associated virus-2 (AAV-2) causes trophoblast dysfunction, and placental AAV-2 infection is associated with preeclampsia.Birth weight and ponderal index in pre-eclampsia: a comparative study.Human cytomegalovirus-caused damage to placental trophoblasts mediated by immediate-early gene-induced tumor necrosis factor-alpha.Thrombin receptors and protease-activated receptor-2 in human placentation: receptor activation mediates extravillous trophoblast invasion in vitro.Role of hypoxia-inducible transcription factors 1alpha and 2alpha in the regulation of plasminogen activator inhibitor-1 expression in a human trophoblast cell lineRole of the fetoplacental endothelium in fetal growth restriction with abnormal umbilical artery Doppler velocimetry.Unilateral uterine ischemia/reperfusion-induced bilateral fetal loss and fetal growth restriction in a murine model require intact complement component 5.Inherited thrombophilia profile in patients with recurrent miscarriages: Experience from a tertiary care center in north India.Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance.Placental histopathologic features in patients with thrombophilic mutations.Correlation between First and Second Trimester Uterine Artery Doppler Velocimetry and Placental Bed Histopathology.Maternal serum 25-hydroxyvitamin D and placental vascular pathology in a multicenter US cohort.Impact of fetal versus perinatal hypoxia on sex differences in childhood outcomes: developmental timing mattersProtein composition of microparticles shed from human placenta during placental perfusion: Potential role in angiogenesis and fibrinolysis in preeclampsiaDisease-Modifying Drug Possibly Linked to Placental Insufficiency: Severe placental complications in a pregnant woman with multiple sclerosis.Fetal growth and timing of parturition in humans.Placental vascular pathology findings and pathways to preterm deliveryPlacental glucose transporter 3 (GLUT3) is up-regulated in human pregnancies complicated by late-onset intrauterine growth restriction.Role of the syncytium in placenta-mediated complications of preeclampsia.Histopathological analysis of the placental lesions in pregnancies complicated with IUGR and stillbirths in comparison with noncomplicated pregnancies.Thrombosis during pregnancy: Risks, prevention, and treatment for mother and fetus--harvesting the power of omic technology, biomarkers and in vitro or in vivo models to facilitate the treatment of thrombosis.Onset of human preterm and term birth is related to unique inflammatory transcriptome profiles at the maternal fetal interface.Placental histological patterns and uterine artery Doppler velocimetry in pregnancies complicated by early or late pre-eclampsia.Placental and Clinical Characteristics of Term Small-for-Gestational-Age Neonates: A Case-Control Study.Protein S deficiency complicated pregnancy in women with recurrent pregnancy loss.Working Towards a Reproducible Method for Quantifying Placental Syncytial Knots.Placental Dysfunction Underlies Increased Risk of Fetal Growth Restriction and Stillbirth in Advanced Maternal Age Women
P2860
Q24801115-ADF2B05C-EC16-4F4A-809F-E65F41F7C7A3Q24802453-C721EA9F-75BF-4A40-A29A-C34C30A62E17Q27000083-B41C962B-E405-440A-89E1-34F742B61376Q27021167-A2257330-309F-4A19-B353-710C09FF6ADBQ31125958-7D8F785A-157F-4ED3-8B83-FF50ED308BB5Q33331154-12C5F249-68CD-413C-A47E-716B53299586Q33624405-E328B481-01D7-47DA-80FE-ED7CDFB3641BQ33886558-790A2497-C4C4-464A-BEE1-ADBC9E72606CQ34200215-B364D73C-CAA5-4869-8D21-07D95C2E8073Q34568696-43F5D334-5FAB-49CF-8758-32B565E96D45Q34698765-DAB32856-208D-4680-8EBA-190322DE712EQ34730977-BC6C96BD-138B-44B4-A241-9BAB45B455A7Q34790582-4FEFDF67-64D5-4B1F-90B4-B23689E85435Q35088398-9B5522D5-71E4-46C1-8DA8-33B2A782A6A2Q35623132-3E90CEFC-F5FD-40AE-9D9C-4FCBC5813591Q35789277-72F1DC60-EB54-4AC5-967B-00CCB44B6D76Q35792220-0E54AC36-20D4-4675-8099-56206E3E980EQ36026570-3863E5AC-4B46-4D45-BD04-3892757B17C9Q36118240-6702E02D-B7A4-44CF-A4D4-1D323421BD64Q36205244-B09D1D32-DFDB-4D9A-A11C-B4A2BCE30B51Q36328676-679912AF-3761-4E1D-9DE9-DDC46A7C2310Q36663036-7163D798-AFEA-4B6C-8894-2984BD71C610Q36793046-CDBA9037-2C58-4109-8B4A-615A3B3E5CD0Q36979292-3919DA61-0915-490C-B9A8-D4790E68DEC1Q37016480-20A91A74-8594-4C21-B8C7-12886EE9E104Q37024036-7D9F0C0D-26CB-4701-97D1-43FF17E97469Q37146239-54DAA750-16A1-4F62-A332-DC9ED8342C50Q37200641-4F591A0C-2AF4-45E7-8613-6C566DAAEA55Q37305979-3C8670E5-B226-4B24-B26B-4727E7EBD907Q37306263-23172B49-BEA5-4A77-96BF-50FD9943A3B8Q37350362-8822108F-4A7C-47C5-8B6A-602599E0D9BDQ37394622-06052382-CAC7-49B9-A6D3-DBA317553172Q37611082-68082121-FADE-4E18-AF5D-4B1FEC5F5016Q38592484-2C50203A-3636-482B-8DAB-05A1B55C7CC9Q40054555-3BB461B9-EDEA-4607-A5E3-7CAD1B1B6ADAQ40382216-7F559539-2C76-49BD-8F5A-02F386B95837Q40541148-17E774BB-4A2B-4A7B-8953-424A38F5376CQ40872616-C7D75053-FB73-4215-AD3E-BA6F15EEF3F1Q41154655-B00590A6-9177-43E6-8678-BE07ED21716BQ41547479-BD63D49B-6392-4073-BD2C-DAAB4768BD60
P2860
Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features
description
1995 nî lūn-bûn
@nan
1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Intrauterine growth restrictio ...... placental pathologic features
@ast
Intrauterine growth restrictio ...... placental pathologic features
@en
Intrauterine growth restrictio ...... placental pathologic features
@nl
type
label
Intrauterine growth restrictio ...... placental pathologic features
@ast
Intrauterine growth restrictio ...... placental pathologic features
@en
Intrauterine growth restrictio ...... placental pathologic features
@nl
prefLabel
Intrauterine growth restrictio ...... placental pathologic features
@ast
Intrauterine growth restrictio ...... placental pathologic features
@en
Intrauterine growth restrictio ...... placental pathologic features
@nl
P2093
P1476
Intrauterine growth restrictio ...... placental pathologic features
@en
P2093
A M Vintzileos
C M Salafia
J C Pezzullo
T S Rosenkrantz
V K Minior
P304
P356
10.1016/0002-9378(95)91325-4
P407
P577
1995-10-01T00:00:00Z